Clinical trial
Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.
NCT00124059 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00124059 |
|---|---|
| Title | Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence. |
| Official title | A Double-Blind Study of Quetiapine Fumarate (Seroquel) for the Treatment of Type A vs.Type B Alcoholics. |
| Lead sponsor | University of Pennsylvania, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | Seroquel, Placebo |
| Enrollment | 61 |
| Start date | Mar 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Jul 26, 2005 |
| Last update posted | Oct 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: